Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 65 OF 66 | DISPLAYING 961 - 975 OF 983 RESULTS

    Grisanzio C. et al., Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis., [Epub ahead of print]., PNAS, Jun 22, 2012

    Wu J. et al., The Pro-inflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma., [Epub ahead of print]., Cancer Res., Jun 19, 2012

    Balko J.M. et al., Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance., [Epub ahead of print]., Nat Med, Jun 10, 2012

    Larsson O, et al., Distinct perturbation of the translatome by the antidiabetic drug metformin., [Epub ahead of print]., PNAS, May 18, 2012

    Morris C, et al., INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells, 72(8):2006-16., Cancer Res., Apr 15, 2012

    Laborde RR, et al., Transcriptional Profiling by Sequencing of Oropharyngeal Cancer, 87(3):226-232. (2012). doi:10.1016/j.mayocp.2011.10.008., Mayo Clin Proc. , Mar 01, 2012

    O’Connor CM, et al., Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy, 2:249. Epub Feb 13. (2012)., Sci Rep, Feb 13, 2012

    Janus JR, et al., Linking Expression of FOXM1, CEP55 and HELLS to Tumorigenesis in Oropharyngeal Squamous Cell Carcinoma, 121(12): 2598-603., The Laryngoscope, Dec 01, 2011

    Wang W, et al., MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response, Nov 18. [Epub ahead of print]. (2011)., Haematologica, Nov 18, 2011

    Northcott PA, et al., Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples, 123(4): 615-26., Acta Neuropathologica, Nov 06, 2011

    Santagata S, et al., Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein Homeostasis, 17;7(2):340-9. (2012)., ACS Chem Biol. , Nov 03, 2011

    Martin S.E. et al., RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors., 11(8): 976–986., Curr Cancer Drug Targets, Oct 01, 2011

    Delmore JE, et al., BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc, 146(6):904-17., Cell, Sep 16, 2011

    Welch JS, et al., Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study, 86(9):796-800., Am J Hematol, Aug 03, 2011

    Manning G, et al., Assessing a new gene expression analysis technique for radiation biodosimetry applications, [Epub ahead of print]., Radiation Measurements, May 11, 2011